Loading...
BRM270 Suppresses Cervical Cancer Stem Cell Characteristics and Progression by Inhibiting SOX2
Background/Aim: Cervical cancer is one of the leading causes of cancer death in women worldwide. BRM270 (BRMLife) has therapeutic potential for cancer treatment owing to its ability to inhibit cell proliferation, and expression of cluster of differentiation (CD) 133 in CD133(+) cancer cells. This st...
Saved in:
| Published in: | In Vivo |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
International Institute of Anticancer Research
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7279830/ https://ncbi.nlm.nih.gov/pubmed/32354896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11879 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|